BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 109 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $609,000 | -33.3% | 29,973 | -0.4% | 0.01% | -30.0% |
Q3 2021 | $913,000 | +10.7% | 30,086 | +6.0% | 0.02% | +11.1% |
Q2 2021 | $825,000 | -13.5% | 28,380 | +28.4% | 0.02% | -14.3% |
Q1 2021 | $954,000 | +9.5% | 22,104 | +17.2% | 0.02% | +23.5% |
Q4 2020 | $871,000 | +32.6% | 18,863 | +24.6% | 0.02% | -5.6% |
Q3 2020 | $657,000 | – | 15,141 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |